EXHIBIT 31.2

I, Edward J. Weisberger, certify that:

1.   I have reviewed this Annual report on Form 10-KSB for fiscal
     year 2003 of Igene Biotechnology, Inc.;

2.   Based  on  my  knowledge, this report does not  contain  any
     untrue  statement  of  a material  fact  or  omit to state a
     material  fact  necessary  to  make  the statements made, in
     light of the circumstances  under which such statements were
     made,  not  misleading with respect to the period covered by
     this report;

3.   Based  on  my knowledge, the financial statements, and other
     financial  information  included  in  this  report,   fairly
     present  in  all  material respects the financial condition,
     results of  operations  and cash flows of the small business
     issuer as of, and for, the periods presented in this report;

4.   The   registrant's  other  certifying  officers  and  I  are
     responsible  for  establishing  and  maintaining  disclosure
     controls  and procedures (as defined in Exchange  Act  Rules
     13a-14 and 15d-14) for the registrant and have

     a)   Designed  such  disclosure controls and procedures,  or
          caused  such disclosure controls and procedures  to  be
          designed under our supervision, to ensure that material
          information  relating  to the  small  business  issuer,
          including its consolidated subsidiaries, is made  known
          to  us  by  others within those entities,  particularly
          during  the  period  in  which  this  report  is  being
          prepared;

     b)   Evaluated  the  effectiveness  of  the  small  business
          issuer's   disclosure  controls  and   procedures   and
          presented  in  this  report our conclusions  about  the
          effectiveness   of   the   disclosure   controls    and
          procedures, as of the end of the period covered by this
          report based on such evaluation; and

     c)   Disclosed  in  this  report any  change  in  the  small
          business  issuer's internal control financial reporting
          that  occurred during the small business issuer's  most
          recent  fiscal  quarter  (the small  business  issuer's
          fourth  fiscal quarter in the case of an annual report)
          that  has materially affected, or is reasonably  likely
          to  materially  affect,  the  small  business  issuer's
          internal control over financial reporting; and

5.   The  small business issuer's other certifying officer and  I
     have  disclosed,  based  on our most  recent  evaluation  of
     internal  control  over financial reporting,  to  the  small
     business  issuer's auditors and the audit committee  of  the
     small  business  issuer's  board of  directors  (or  persons
     performing the equivalent):

     a)   All significant deficiencies and material weaknesses in
          the  design  or  operation  of  internal  control  over
          financial  reporting  which are  reasonably  likely  to
          adversely affect the small business issuer's ability to
          record,   process,   summarize  and  report   financial
          information; and

     b)   Any  fraud,  whether  or  not material,  that  involves
          management  or  other employees who have a  significant
          role  in  the small business issuer's internal  control
          over financial reporting.



Date: March 26, 2004

/s/ EDWARD J. WEISBERGER
_______________________________
     EDWARD J. WEISBERGER
     Chief Financial Officer